⚠️ Research/education only. Statements about this compound haven’t been evaluated by the FDA; it isn’t intended to diagnose, treat, cure, or prevent disease.
Bpc157 + TB500
Peptide Bottle
$70.00
- C62H98N16O22
- C212H350N56O78S
- 15 aa
- 43 aa
A research blend of two synthetic peptides: BPC-157, a stable gastric pentadecapeptide (15 aa) derived from the human gastric-juice protein BPC, and TB-500, the full-length synthetic thymosin beta-4 polypeptide (43 aa) involved in G-actin sequestration and cytoskeletal dynamics. Both components have been studied in preclinical and in-vitro model systems for angiogenic signaling, nitric-oxide pathway modulation, and actin-mediated cell migration — with no approved human therapeutic indication.
10mg
Quantity
⚠️ FDA hasn’t evaluated our statements; efficacy isn’t confirmed by FDA—products aren’t intended to diagnose, treat, cure, or prevent disease.